AbbVie
ABBV
$283.00
Share price
2.17%
Change (1 day)
8.31%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
Market capitalization of AbbVie (ABBV)
Market cap: A$500.62 Billion
As of April 2025 AbbVie has a market cap of A$500.62 Billion. This makes AbbVie the world's 28th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of AbbVie from 2012 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | A$500.62 B | -1.01% |
| 2024 | A$505.73 B | 25.93% |
| 2023 | A$401.59 B | -4.38% |
| 2022 | A$419.98 B | 27.2% |
| 2021 | A$330.17 B | 34.21% |
| 2020 | A$246.01 B | 31.54% |
| 2019 | A$187.02 B | -3.36% |
| 2018 | A$193.52 B | -2.14% |
| 2017 | A$197.75 B | 40.08% |
| 2016 | A$141.17 B | 7.84% |
| 2015 | A$130.91 B | 2.88% |
| 2014 | A$127.24 B | 35.4% |
| 2013 | A$93.98 B | 80.95% |
| 2012 | A$51.93 B |
End of Day market cap according to different sources
On Apr 23rd, 2025 the market cap of AbbVie was reported to be:
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | A$202.52 B | -59.55% | 🇺🇸 USA |
 | A$154.58 B | -69.12% | 🇺🇸 USA |
 | A$1.201 T | 139.99% | 🇺🇸 USA |
 | A$235.74 B | -52.91% | 🇺🇸 USA |
 | A$208.41 B | -58.37% | 🇺🇸 USA |
 | A$27.41 B | -94.52% | 🇺🇸 USA |
 | A$118.40 B | -76.35% | 🇬🇧 UK |
 | A$337.01 B | -32.68% | 🇬🇧 UK |
 | A$16.19 B | -96.76% | 🇺🇸 USA |